; or (B) protect the public health. (2) Modifications after submission of report After the date on which the report described in section 3204(b) of the SUPPORT for Patients and Communities Act is submitted, the Attorney General, in coordination with the Secretary, may modify the number of days described in subsection (a)(5). (3) Minimum number of days Any modification under this subsection shall be for a period of not less than 7 days. . (b) Study and report Not later than 2 years after the date of enactment of this section, the Comptroller General of the United States shall conduct a study and submit to Congress a report on access to and potential diversion of controlled substances administered by injection or implantation. (c) Technical and conforming amendment The table of contents for the Comprehensive Drug Abuse Prevention and Control Act of 1970 is amended by inserting after the item relating to section 309 the following: Sec. 309A. Delivery of a controlled substance by a pharmacy to an administering practitioner. . 2 Empowering Pharmacists in the Fight Against Opioid Abuse 3211. Short title This chapter may be cited as the Empowering Pharmacists in the Fight Against Opioid Abuse Act . 3212. Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription (a) In general Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate, as appropriate, materials for pharmacists, health care providers, and patients on— (1) circumstances under which a pharmacist may, consistent with section 309 of the Controlled Substances Act ( 21 U.S.C. 829 ) and regulations thereunder, including section 1306.04 of title 21, Code of Federal Regulations, decline to fill a